Where is Advicenne’s corporate headquarters?
Advicenne has three offices, all located in France.The headquarters are located in Paris and house commercial and financial activities.
Clinical and regulatory activities take place in Nîmes. The pharmaceutical development department is located in the office in Montbonnot near Grenoble.
Nîmes : 21 allée Boissy d’Anglas – 30000 Nîmes
Grenoble : 445, Rue Lavoisier – 38330 Montbonnot St Martin
Paris : 22, Rue de la Paix – 75002 Paris
When was the company founded?
Advicenne was founded in 2007 by Luc-André Granier and Caroline Roussel-Maupetit with the objective of developing and commercialising orphan drugs suitable for patients of all ages, and especially children, in the fields of neurology and nephrology.
When did Advicenne go public?
The Initial Public Offering took place in December 2017 on EURONEXT Paris. 27,8M€ has been raised.
On which markets is Advicenne listed?
Advicenne is cross-listed on Euronext Paris and Brussels (ADVIC – ISIN Code: FR0013296746).
Why is Advicenne listed on two stock markets?
The proposed cross-listing aims to further increase the visibility of Advicenne’s shares in Belgium and beyond, and fits well with the ongoing clinical developments of Advicenne in Belgium, where the company is conducting a Phase II/III clinical study with its lead product, ADV7103, for the treatment of cystinuria, a rare nephrological disease.
How is Advicenne’s stock traded?
Advicenne’s common stock is listed on Euronext under the symbol ADVIC.
What is Advicenne’s fiscal year?
Advicenne’s fiscal year ends December 31st.
How can I buy shares of the company? Who should I contact in order to do so?
You can contact your own bank or a good online broker.
How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
For all your questions related to your registered shares, you can contact BNPParibas, the bank that is in charge of Advicenne’s share register. They can be contacted by mail at the following address: firstname.lastname@example.org.
Does Advicenne have a direct stock purchase plan?
Advicenne does not have a stock purchase plan.
Who is Advicenne’s auditor?
The auditors of Advicenne are:
- KPMG, represented by Stéphane Devin, associate – 51, Rue Saint Cyr, 69338 LYON cedex
- Implid, represented by Alain Descoins, associate – 170, Boulevard de Stalingrad, 69006 LYON
Whom should I contact for investor inquiries?
Please send investor inquiries to email@example.com.
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.
© 2019 Advicenne